| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $15.0M | +1766.5% |
| R&D Expense | $42.2M | -5.9% |
| SG&A Expense | $29.7M | -25.5% |
| Operating Income | -$68.0M | +19.0% |
| Pre-tax Income | -$61.2M | +20.0% |
| Income Tax | -$44K | +98.6% |
| Net Income | -$61.1M | +16.7% |
| EPS (Basic) | -$1.55 | +18.8% |
| EPS (Diluted) | -$1.55 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $110.7M | -22.1% |
| Current Assets | $125.7M | -19.9% |
| Total Assets | $160.3M | -25.3% |
| Current Liabilities | $15.7M | +24.3% |
| Total Liabilities | $30.2M | +9.7% |
| Stockholders' Equity | $130.0M | -30.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.9M | +43.2% |
| Capital Expenditures | $892K | -83.5% |
| Investing Cash Flow | -$892K | +83.5% |
| Financing Cash Flow | $2.2M | +15.5% |
| Free Cash Flow | -$29.8M | +47.0% |
| +18.8% |